Asko Järvinen

6.4k total citations · 1 hit paper
126 papers, 4.0k citations indexed

About

Asko Järvinen is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Asko Järvinen has authored 126 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 39 papers in Epidemiology and 30 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Asko Järvinen's work include Antimicrobial Resistance in Staphylococcus (32 papers), Streptococcal Infections and Treatments (26 papers) and Bacterial Identification and Susceptibility Testing (23 papers). Asko Järvinen is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (32 papers), Streptococcal Infections and Treatments (26 papers) and Bacterial Identification and Susceptibility Testing (23 papers). Asko Järvinen collaborates with scholars based in Finland, Sweden and United Kingdom. Asko Järvinen's co-authors include Terho Heikkinen, Ville Valtonen, Eeva Ruotsalainen, Hilpi Rautelin, Soile Tynkkynen, Minna Salminen, Maija Saxelin, Tuija Poussa, Erik Forsblom and Petri Ruutu and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Asko Järvinen

118 papers receiving 3.8k citations

Hit Papers

The common cold 2003 2026 2010 2018 2003 200 400 600

Peers

Asko Järvinen
Comparison fields: 5 of 142
  • Infectious Diseases 1.3k
  • Epidemiology 1.2k
  • Molecular Biology 843
  • Food Science 692
  • Public Health, Environmental and Occupational Health 495
Bernard Rudensky Israel
Rama Chaudhry India
Rosa del Campo Spain
Andi L. Shane United States
David R. Murdoch New Zealand
Theodoros Kelesidis United States
G. Potel France
Erkki Eerola Finland
Harri Saxén Finland
Nina Langeland Norway
Bernard Rudensky Israel View profile →
Citations per field, relative to Asko Järvinen
Asko Järvinen · 1×
Citations per year, relative to Asko Järvinen
Asko Järvinen · 1×

Countries citing papers authored by Asko Järvinen

Since Specialization
Citations

This map shows the geographic impact of Asko Järvinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asko Järvinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asko Järvinen more than expected).

Fields of papers citing papers by Asko Järvinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asko Järvinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asko Järvinen. The network helps show where Asko Järvinen may publish in the future.

Co-authorship network of co-authors of Asko Järvinen

This figure shows the co-authorship network connecting the top 25 collaborators of Asko Järvinen. A scholar is included among the top collaborators of Asko Järvinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asko Järvinen. Asko Järvinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Infective Endocarditis in People Who Inject Drugs—A 5-Year Follow-up: “I’ve Seen the Needle and the Damage Done” Open Forum Infectious Diseases Veli‐Jukka Anttila, Asko Järvinen et al. 1
2 Effectiveness of COVID-19 vaccination among dialysis and kidney transplant patients compared with matched controls—a nationwide cohort study Clinical Microbiology and Infection Elisa Kortela, Jaakko Helve et al. 0
3 Healthcare-associated infective endocarditis: source of infection and burden of previous healthcare exposure SHILAP Revista de lepidopterología Kaisa Huotari, Veli‐Jukka Anttila et al. 3
4 Incidence and outcome of hospital-acquired COVID-19 infections in secondary and tertiary care hospitals in the era of COVID-19 vaccinations SHILAP Revista de lepidopterología Erik Forsblom, Katariina Kainulainen et al. 0
5 Women report more symptoms and impaired quality of life: a survey of Finnish COVID-19 survivors STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) Anna Lindahl, Mika J. Mäkelä et al. 0
6 Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia PLoS ONE Erik Forsblom, Jaana Syrjänen et al. 5
7 SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors Travel Medicine and Infectious Disease Anu Kantele, Tinja Lääveri et al. 30
8 Suspicion of Lyme borreliosis in patients referred to an infectious diseases clinic: what did the patients really have? Clinical Microbiology and Infection Elisa Kortela, Mari Kanerva et al. 10
9 Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia PLoS ONE Eeva Ruotsalainen, Esa Rintala et al. 18
10 Improved Outcome with Early Rifampicin Combination Treatment in Methicillin-Sensitive Staphylococcus aureus Bacteraemia with a Deep Infection Focus – A Retrospective Cohort Study PLoS ONE Erik Forsblom, Eeva Ruotsalainen et al. 20
11 Two cases of food-borne botulism in Finland caused by conserved olives, October 2011 STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) Katri Jalava, Elina Kolho et al. 4
12 The Efficacy and Safety of ProbioticLactobacillus rhamnosusGG on Prolonged, Noninfectious Diarrhea in HIV Patients on Antiretroviral Therapy: A Randomized, Placebo-Controlled, Crossover Study HIV Clinical Trials Minna Salminen, Soile Tynkkynen et al. 84
13 Genome diversification in Staphylococcus aureus Infection and Immunity Sean D. Reid, Eeva Ruotsalainen et al. 3
14 The common cold breakdown → The Lancet Terho Heikkinen, Asko Järvinen 733
15 Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch Maturitas Asko Järvinen et al. 24
16 Folate, vitamin D, and iron intakes are low among pregnant Finnish women European Journal of Clinical Nutrition Maijaliisa Erkkola, Asko Järvinen et al. 67
17 Steady‐state pharmacokinetics of oestradiol gel in post‐menopausal women: effects of application area and washing BJOG An International Journal of Obstetrics & Gynaecology Asko Järvinen, Sirkka Nykänen et al. 20
18 Pharmacokinetics of tinidazole in dogs and cats Journal of Veterinary Pharmacology and Therapeutics Asko Järvinen, M. Mero et al. 6
19 Selective cardiorespiratory activity of an iodinated analog of thyrotropin-releasing hormone (TRH) Peptides Ilari Paakkari, Asko Järvinen et al. 8
20 Opioid peptides derived from in vitro proteolysis of whey proteins. Jukuri (Natural Resources Institute Finland (Luke)) Ilari Paakkari, Asko Järvinen et al. 3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026